Onyx Pharmaceuticals Inc

Formerly NASDAQ: ONXX

Underwriting Agreements Filter

EX-1.1
from 8-K 34 pages Onyx Pharmaceuticals, Inc. 4,400,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.2
from 8-K 40 pages Onyx Pharmaceuticals, Inc. 4.00% Convertible Senior Notes Due 2016 Underwriting Agreement
12/34/56
EX-1.1
from 8-K 32 pages Onyx Pharmaceuticals, Inc. 4,000,000 Shares of Common Stock Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1.1
from 8-K 32 pages 6,600,000 Shares Onyx Pharmaceuticals, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G/A 1 page Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934
12/34/56
EX-1
from SC 13G 1 page <page> Exhibit 1 Power of Attorney for Certain Filings Under the Securities Exchange Act of 1934 I, David E. Shaw, Hereby Make, Constitute and Appoint Each Of: Anne Dinning, Julius Gaudio, Lou Salkind, Stuart Steckler, and Eric Wepsic, Acting Individually, as My Agent and Attorney-In-Fact, With Full Power of Substitution, for the Purpose Of, From Time to Time, Executing in My Name and/or My Capacity as President of D. E. Shaw & Co., Inc. (Acting for Itself or as the General Partner of D. E. Shaw & Co., L. P. and General Partner or Managing Member of Other Entities, Any Which in Turn May Be Acting for Itself or Other Entities) All Documents, Certificates, Instruments, Statement, Other Filings, and Amendments to the Forgoing (Collectively, "Documents") Determined by Such Person to Be Necessary or Appropriate to Comply With Ownership or Control-Person Reporting Requirements Imposed by Any United States or Non-United States Governmental or Regulatory Authority, Including Without Limitation Forms 3, 4, 5, 13d, 13f, and 13g Required to Be Filed With the Securities and Exchange Commission; and Delivering, Furnishing or Filing Any Such Documents With the Appropriate Governmental or Regulatory Authority. Any Such Determination Shall Be Conclusively Evidenced by Such Person's Execution, Delivery, Furnishing, and/or Filing of the Applicable Document. This Power of Attorney Shall Be Valid From the Date Hereof and Replaces the Power Granted on February 5, 2001, Which Is Hereby Cancelled. in Witness Hereof, I Have Executed This Instrument as of the Date Set Forth Below. Date: February 24, 2004 David E. Shaw, as President of D. E. Shaw & Co., Inc. /S/ David E. Shaw New York, New York
12/34/56
EX-1.1
from 8-K 22 pages 5,000,000 Shares Onyx Pharmaceuticals, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K 23 pages 4,637,000 Shares Onyx Pharmaceuticals, Inc. Common Stock, Par Value $0.001 Per Share Underwriting Agreement
12/34/56
EX-1.1
from 8-K ~20 pages Underwriting agreement
12/34/56
EX-1.1
from SC 13G/A 1 page Exhibit 1.1 Joint Filing Agreement the Undersigned Hereby Agree That the Statement on This Schedule 13g/A, Dated February 14, 2003, (The "Schedule 13g/A"), With Respect to the Common Stock, Par Value $0.001 Per Share, of Onyx Pharmaceuticals Inc. Is Filed on Behalf of Each of US Pursuant to and in Accordance With the Provisions of Rule 13d-1(k) Under the Securities and Exchange Act of 1934, as Amended, and That This Agreement Shall Be Included as an Exhibit to This Schedule 13g/A. Each of the Undersigned Agrees to Be Responsible for the Timely Filing of the Schedule 13g/A, and for the Completeness and Accuracy of the Information Concerning Itself Contained Therein. This Agreement May Be Executed in Any Number of Counterparts, All of Which Taken Together Shall Constitute One and the Same Instrument. in Witness Whereof, the Undersigned Have Executed This Agreement as of the 14th Day of February, 2003. Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President Orbimed Advisors LLC By: /S/ Samuel D. Isaly Name: Samuel D. Isaly Title: President of Managing Member, Orbimed Advisors Inc. By: /S/ Samuel D. Isaly Name: Samuel D. Isaly
12/34/56
EX-1.1
from S-3/A ~50 pages Underwriting agreement
12/34/56